Related Experiment Video
Updated: Jun 6, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Is the NIH policy for sharing GWAS data running the risk of being counterproductive?
Michael Krawczak1, Jürgen W Goebel, David N Cooper
1Institut für Medizinische Informatik und Statistik, Christian-Albrechts-Universität zu Kiel, Arnold-Heller-Straße 3, Haus 31, 2105 Kiel, Germany. krawczak@medinfo.uni-kiel.de.
Abstract:
Through their current policy on data sharing, the National Institutes of Health (NIH) are inadvertently placing a serious and potentially insuperable burden upon non-US researchers who perform patient-based genomics studies in collaboration with US institutions. Because this policy could adversely affect future transnational scientific collaborations, we explore some of its likely consequences and suggest possible courses of remedial action wherever feasible.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence studies: Biowaivers
Pharmacogenomics: Identification of New Drug Targets
Bias in Epidemiological Studies
What is Genetic Engineering?
